AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $84.42, giving the company a market capitalization of 261.93B. It carries a P/E multiple of 31.21 and pays a dividend yield of 1.8%.
On 2025-11-07, AstraZeneca(AZN) stock traded between a low of $84.23 and a high of $84.74. Shares are currently priced at $84.42, which is +0.2% above the low and -0.4% below the high.
AstraZeneca(AZN) shares are trading with a volume of 659.7K, against a daily average of 4.46M.
During the past year, AstraZeneca(AZN) stock moved between $61.24 at its lowest and $86.57 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $61.24 at its lowest and $86.57 at its peak.
AZN News
AstraZeneca (AZN) CEO Pascal Soriot has warned that if the U.K. does not increase spending on new drugs, it could eventually be limited to only affordable gener...
Full results from the NATRON Phase III trial showed AstraZeneca’s (AZN) Fasenra demonstrated a statistically significant delay in the time to first worsening or...
AstraZeneca ( (AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. Meet Your ETF AI Analyst Di...
Analyst ratings
81%
of 32 ratingsMore AZN News
Fueled by gains in all of its therapeutic areas, the company had a triumphant third quarter. Veteran pharmaceutical company AstraZeneca (AZN +3.23%) delivered...
AstraZeneca Plc (NASDAQ:AZN) on Thursday reported third-quarter 2025 sales of $15.19 billion, up 12% year over year (+10% at constant currency), beating the con...
AstraZeneca (AZN) stock popped early Thursday after the pharma company reported earnings of $2.38 per share on $15.19 billion in third-quarter sales. On averag...
Reports Q3 revenue $15.2B, consensus $15.36B. Pascal Soriot, Chief Executive Officer, AstraZeneca (AZN), commenting on the results said: “The strong underlying...
(RTTNews) - European stocks drifted lower on Thursday despite a broad market recovery in the U.S. and in overnight trade in Asia. Regional losses remained limi...
(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) reported Thursday significantly higher profit in its third quarter with good growth in revenues. Co...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...